Perspective Therapeutics (CATX) Long-Term Debt Repayments (2010 - 2026)

Perspective Therapeutics has disclosed Long-Term Debt Repayments across 6 years of filings, most recently posting $15000.0 for Q1 2026.

• Long-Term Debt Repayments for Q1 2026 came in at $15000.0, up 15.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $54000.0 (up 10.2% YoY), and the FY2025 annual result was $52000.0, up 8.33% from the prior year.
• Long-Term Debt Repayments came in at $15000.0 for Q1 2026 at Perspective Therapeutics, up from $13000.0 in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $21000.0 in Q3 2023 to a low of $8000.0 in Q2 2024.
• The 4-year median for Long-Term Debt Repayments is $13000.0 (2025), against an average of $14076.9.
• Across the five-year window, Long-Term Debt Repayments plunged 60.0% in 2024 and jumped 62.5% in 2025, its largest moves.
• Perspective Therapeutics' Long-Term Debt Repayments stood at $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then gained by 8.33% to $13000.0 in 2025, then grew by 15.38% to $15000.0 in 2026.
• The last three Long-Term Debt Repayments figures came in at $15000.0 (Q1 2026), $13000.0 (Q4 2025), and $13000.0 (Q3 2025), per Business Quant data.